The health regulator NICE has issued new guidance recommending that women with polyendocrine metabolic ovarian syndrome (PMOS) undergo annual health checks. This initiative aims to improve diagnosis and management of the condition, which affects millions of women in the UK and is often under-diagnosed. The checks will focus on both immediate symptoms and long-term health risks associated with PMOS, such as diabetes and heart disease.
Despite the lack of a cure, the NHS provides treatments to manage symptoms. The guidelines also emphasize the importance of mental health support, as many women with PMOS experience depression and anxiety. The draft guidance is open for consultation until August 2026, with final recommendations expected by December 2026.
With NICE's new guidance, women with PMOS should prioritize annual health checks to address both immediate symptoms and long-term risks. Readers should monitor the consultation process until August 2026 and advocate for mental health support as part of comprehensive care.